Request Information

For more information and to have someone from our office contact you, please fill out the form below.

Our office hours are:

Monday: 8:00am – 4:00pm
Tuesday (Pahrump only): 10:00 am – 3:00 pm
Wednesday:  8:00am – 4:00pm
Thursday:  8:00am – 4:00pm
Friday: 8:00am – 2:30pm

We also have a 24/7 answering service. Please call us anytime at 1-800-881-4226 or 702-508-9128.

Name*

Email*

Address*

Phone

Message

slide_0

NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers

07/24/17

The nationwide precision medicine trial will enroll children and adolescents with advanced cancers that haven’t responded to standard therapy to explore treatments targeted at specific genetic mutations. …read more Source:: Cancer


TCGA study of liver cancer reveals potential targets for therapy

06/15/17

Only two drugs are FDA-approved for liver cancer. This study of hepatocellular carcinoma found genetic alterations in tumors—including mutations in tumor-suppressing genes and high expression of immune checkpoint genes—that could be targets for drugs that already exist. …read more Source:: … Read More


Don’t Fry Day: Getting Sunscreen Right

05/25/17

By David Sampson Despite increased awareness about the dangers of ultraviolet (UV) radiation, melanoma rates continue to rise in the United States. For “Don’t Fry Day” on May 26, the American Cancer Society is cautioning that many people may be … Read More


Ventilated Filters: Changing the Face of Lung Cancer in the U.S.

05/23/17

By David Sampson An analysis appearing in the Journal of the National Cancer Institute finds strong evidence that adding ventilation holes to cigarette filters has contributed to a rise in a type of lung cancer called adenocarcinoma among smokers. The … Read More


Study estimates number of U.S. women living with metastatic breast cancer

05/18/17

A new study shows that the number of women in the United States living with distant metastatic breast cancer (MBC), the most severe form of the disease, is growing. This is likely due to the aging of the U.S. population … Read More


14: The Unmentioned Number in the Prostate Cancer/Coffee Story

05/05/17

By David Sampson Headlines across the Internet blared with the news over the past week that coffee could cut the risk of prostate cancer in half. It was an irresistible headline. But just how reliable was the finding? What if … Read More


Panel Re-Opens the Door for PSA Screening in Men 55-69

04/11/17

By David Sampson The U.S. Preventive Services Task Force (USPSTF) has released draft recommendations for the use of prostate-specific antigen (PSA) screening for prostate cancer. The recommendation, which awaits public comment before being finalized, says the decision about whether to … Read More


Annual Report to the Nation: Cancer death rates continue to decline

03/31/17

According to the latest Annual Report to the Nation on the Status of Cancer, 1975-2014, overall cancer death rates continue to decrease in men, women, and children for all major racial and ethnic groups. But more work remains for some … Read More


The ‘Bad Luck’ Cancer Analysis, Part II

03/25/17

By David Sampson A new study revisits an analysis made by the same lab in 2015 about the role of random mutations on cancer. The analysis uses computer modeling to estimate how many cancers are the result of replication errors. … Read More


ACS Study: Finds Colorectal Cancer Rates Have Risen Dramatically in Gen X and Millennials

02/28/17

By David Sampson A groundbreaking study by American Cancer Society epidemiologist Rebecca Siegel, MPH finds that people born in the United States in 1990 have double the risk of colon cancer and quadruple the risk of rectal cancer compared to … Read More